What does CUSIP 501147102 represent in this 13F holders report?

CUSIP 501147102 is the security identifier for KRYS - Krystal Biotech, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held KRYS - Krystal Biotech, Inc. - Common Stock in Q2 2023?

182 institutional investors reported KRYS - Krystal Biotech, Inc. - Common Stock for Q2 2023. Use the holders table for investor-level position and value details.

Krystal Biotech, Inc. - Common Stock (KRYS)

CUSIP: 501147102

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock
Shares outstanding: 29,289,327
Total 13F shares: 23,039,160
Share change: +2,069,187
Total reported value: $2,704,675,917
Put/Call ratio: 86%
Price per share: $117.40
Number of holders: 182
Value change: +$256,730,169
Number of buys: 99
Number of sells: 76

Quarterly Holders Quick Answers

What is CUSIP 501147102?
CUSIP 501147102 identifies KRYS - Krystal Biotech, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 501147102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of KRYS - Krystal Biotech, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	7.5%	2,196,958	$175,888,457	—	31 Mar 2023	13F
Redmile Group, LLC	13F	Company	6.5%	1,913,280	$153,177,197	—	31 Mar 2023	13F
Avoro Capital Advisors LLC	13F	Company	6%	1,750,000	$140,105,000	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	5.9%	1,716,095	$137,390,566	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	4.1%	1,202,230	$96,250,534	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	3.5%	1,026,395	$82,173,184	—	31 Mar 2023	13F
LORD, ABBETT & CO. LLC	13F	Company	3.3%	961,242	$76,957,000	—	31 Mar 2023	13F
Frazier Life Sciences Management, L.P.	13F	Company	3.2%	945,407	$75,689,284	—	31 Mar 2023	13F
CREDIT SUISSE AG/	13F	Company	2.2%	632,824	$50,663,889	—	31 Mar 2023	13F
PICTET ASSET MANAGEMENT SA	13F	Company	2.2%	632,393	$50,629,384	—	31 Mar 2023	13F
Point72 Asset Management, L.P.	13F	Company	1.7%	502,400	$40,222,144	—	31 Mar 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.6%	462,090	$36,994,210	—	31 Mar 2023	13F
Hood River Capital Management LLC	13F	Company	1.5%	447,393	$35,818,000	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.5%	430,571	$34,471,514	—	31 Mar 2023	13F
Artal Group S.A.	13F	Company	1.4%	412,082	$32,991,000	—	31 Mar 2023	13F
Nicholas Investment Partners, LP	13F	Company	1.3%	374,718	$29,999,923	—	31 Mar 2023	13F
BRAIDWELL LP	13F	Company	1.2%	348,036	$27,863,762	—	31 Mar 2023	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	1.1%	311,949	$24,974,637	—	31 Mar 2023	13F
BAKER BROS. ADVISORS LP	13F	Company	1%	302,716	$24,235,443	—	31 Mar 2023	13F
Skandinaviska Enskilda Banken AB (publ)	13F	Company	0.98%	286,018	$22,899,000	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.88%	257,860	$20,644,271	—	31 Mar 2023	13F
JPMORGAN CHASE & CO	13F	Company	0.81%	238,409	$19,087,000	—	31 Mar 2023	13F
C WorldWide Group Holding A/S	13F	Company	0.77%	225,809	$18,078,000	—	31 Mar 2023	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.72%	212,130	$16,983,127	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.69%	201,477	$16,130,248	—	31 Mar 2023	13F
First Light Asset Management, LLC	13F	Company	0.67%	195,980	$15,690,159	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.55%	159,889	$12,800,713	—	31 Mar 2023	13F
ExodusPoint Capital Management, LP	13F	Company	0.46%	136,141	$10,899,000	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.43%	126,825	$10,153,609	—	31 Mar 2023	13F
S Squared Technology, LLC	13F	Company	0.37%	108,215	$8,663,693	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.37%	107,325	$8,592,440	—	31 Mar 2023	13F
Handelsbanken Fonder AB	13F	Company	0.36%	105,200	$8,422,000	—	31 Mar 2023	13F
Verition Fund Management LLC	13F	Company	0.32%	93,644	$7,497,139	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.32%	92,887	$7,436,533	—	31 Mar 2023	13F
Soleus Capital Management, L.P.	13F	Company	0.29%	85,179	$6,819,431	—	31 Mar 2023	13F
Integral Health Asset Management, LLC	13F	Company	0.29%	85,000	$6,805,100	—	31 Mar 2023	13F
S.c.a. Candriam	13F	Individual	0.31%	92,000	$6,779,438	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.27%	79,563	$6,369,814	—	31 Mar 2023	13F
Rafferty Asset Management, LLC	13F	Company	0.21%	61,524	$4,925,611	—	31 Mar 2023	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	0.21%	61,000	$4,883,660	—	31 Mar 2023	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.18%	53,932	$4,317,796	—	31 Mar 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.18%	52,931	$4,238,000	—	31 Mar 2023	13F
Invesco Ltd.	13F	Company	0.18%	51,580	$4,129,495	—	31 Mar 2023	13F
CITIGROUP INC	13F	Company	0.17%	50,585	$4,049,835	—	31 Mar 2023	13F
NORGES BANK	13F	Company	0.16%	48,101	$3,850,966	—	31 Mar 2023	13F
Hennion & Walsh Asset Management, Inc.	13F	Company	0.15%	45,235	$3,622,000	—	31 Mar 2023	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.14%	41,135	$3,293,268	—	31 Mar 2023	13F
Swiss National Bank	13F	Company	0.13%	38,900	$3,114,334	—	31 Mar 2023	13F
CWM, LLC	13F	Company	0.12%	35,165	$2,815,000	—	31 Mar 2023	13F
SILVERARC CAPITAL MANAGEMENT, LLC	13F	Company	0.12%	34,014	$2,723,161	—	31 Mar 2023	13F

Institutional Holders of Krystal Biotech, Inc. - Common Stock (KRYS) as of Q2 2023

As of 30 Jun 2023, Krystal Biotech, Inc. - Common Stock (KRYS) was held by 182 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,039,160 shares. The largest 10 holders included FMR LLC, Redmile Group, LLC, Avoro Capital Advisors LLC, VANGUARD GROUP INC, BlackRock Inc., Frazier Life Sciences Management, L.P., STATE STREET CORP, LORD, ABBETT & CO. LLC, Point72 Asset Management, L.P., and DIMENSIONAL FUND ADVISORS LP. This page lists 182 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

159

Q2 2023 holders

182

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.